Strand Therapeutics Announces Poster Presentation on STX-001 at the 2023 AACR Annual Meeting
BOSTON--(BUSINESS WIRE)--#AACR2023--Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today announced the details of its poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023, being held from April 14 - 19, 2023 in...
Source: pharmiweb.com